img

Global NGS-based RNA-sequencing Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global NGS-based RNA-sequencing Market Research Report 2024

Gene expression studies can also involve looking at profiles or patterns of expression of several genes. RNA sequencing (RNA-Seq) leverages the advantages of next-generation sequencing (NGS) to detect and quantify RNA in a biological sample at a given point in time.
According to Mr Accuracy reports’s new survey, global NGS-based RNA-sequencing market is projected to reach US$ 5746.2 million in 2034, increasing from US$ 1832.5 million in 2024, with the CAGR of 17.4% during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole NGS-based RNA-sequencing market research.
Key companies engaged in the NGS-based RNA-sequencing industry include Illumina, Thermo Fischer Scientific, Oxford Nanopore, Agilent Technologies, BGI, PerkinElmer, QIAGEN, Eurofins Scientific and Roche, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % value of NGS-based RNA-sequencing were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole NGS-based RNA-sequencing market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global NGS-based RNA-sequencing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Illumina
Thermo Fischer Scientific
Oxford Nanopore
Agilent Technologies
BGI
PerkinElmer
QIAGEN
Eurofins Scientific
Roche
Takara Bio
GENEWIZ
Hamilton
Macrogen
Zymo Research
Tecan Genomics
Segment by Type
Sequencing by Synthesis
Ion Semiconductor Sequencing
Single-molecule Real-time Sequencing
Nanopore Sequencing

Segment by Application


Research & Academia
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The NGS-based RNA-sequencing report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global NGS-based RNA-sequencing Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 Sequencing by Synthesis
1.2.3 Ion Semiconductor Sequencing
1.2.4 Single-molecule Real-time Sequencing
1.2.5 Nanopore Sequencing
1.3 Market by Application
1.3.1 Global NGS-based RNA-sequencing Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Research & Academia
1.3.3 Hospitals & Clinics
1.3.4 Pharmaceutical & Biotechnology Companies
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global NGS-based RNA-sequencing Market Perspective (2018-2034)
2.2 NGS-based RNA-sequencing Growth Trends by Region
2.2.1 Global NGS-based RNA-sequencing Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 NGS-based RNA-sequencing Historic Market Size by Region (2018-2023)
2.2.3 NGS-based RNA-sequencing Forecasted Market Size by Region (2024-2034)
2.3 NGS-based RNA-sequencing Market Dynamics
2.3.1 NGS-based RNA-sequencing Industry Trends
2.3.2 NGS-based RNA-sequencing Market Drivers
2.3.3 NGS-based RNA-sequencing Market Challenges
2.3.4 NGS-based RNA-sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top NGS-based RNA-sequencing Players by Revenue
3.1.1 Global Top NGS-based RNA-sequencing Players by Revenue (2018-2023)
3.1.2 Global NGS-based RNA-sequencing Revenue Market Share by Players (2018-2023)
3.2 Global NGS-based RNA-sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by NGS-based RNA-sequencing Revenue
3.4 Global NGS-based RNA-sequencing Market Concentration Ratio
3.4.1 Global NGS-based RNA-sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by NGS-based RNA-sequencing Revenue in 2024
3.5 NGS-based RNA-sequencing Key Players Head office and Area Served
3.6 Key Players NGS-based RNA-sequencing Product Solution and Service
3.7 Date of Enter into NGS-based RNA-sequencing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 NGS-based RNA-sequencing Breakdown Data by Type
4.1 Global NGS-based RNA-sequencing Historic Market Size by Type (2018-2023)
4.2 Global NGS-based RNA-sequencing Forecasted Market Size by Type (2024-2034)
5 NGS-based RNA-sequencing Breakdown Data by Application
5.1 Global NGS-based RNA-sequencing Historic Market Size by Application (2018-2023)
5.2 Global NGS-based RNA-sequencing Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America NGS-based RNA-sequencing Market Size (2018-2034)
6.2 North America NGS-based RNA-sequencing Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America NGS-based RNA-sequencing Market Size by Country (2018-2023)
6.4 North America NGS-based RNA-sequencing Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe NGS-based RNA-sequencing Market Size (2018-2034)
7.2 Europe NGS-based RNA-sequencing Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe NGS-based RNA-sequencing Market Size by Country (2018-2023)
7.4 Europe NGS-based RNA-sequencing Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific NGS-based RNA-sequencing Market Size (2018-2034)
8.2 Asia-Pacific NGS-based RNA-sequencing Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific NGS-based RNA-sequencing Market Size by Region (2018-2023)
8.4 Asia-Pacific NGS-based RNA-sequencing Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America NGS-based RNA-sequencing Market Size (2018-2034)
9.2 Latin America NGS-based RNA-sequencing Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America NGS-based RNA-sequencing Market Size by Country (2018-2023)
9.4 Latin America NGS-based RNA-sequencing Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa NGS-based RNA-sequencing Market Size (2018-2034)
10.2 Middle East & Africa NGS-based RNA-sequencing Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa NGS-based RNA-sequencing Market Size by Country (2018-2023)
10.4 Middle East & Africa NGS-based RNA-sequencing Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Detail
11.1.2 Illumina Business Overview
11.1.3 Illumina NGS-based RNA-sequencing Introduction
11.1.4 Illumina Revenue in NGS-based RNA-sequencing Business (2018-2023)
11.1.5 Illumina Recent Development
11.2 Thermo Fischer Scientific
11.2.1 Thermo Fischer Scientific Company Detail
11.2.2 Thermo Fischer Scientific Business Overview
11.2.3 Thermo Fischer Scientific NGS-based RNA-sequencing Introduction
11.2.4 Thermo Fischer Scientific Revenue in NGS-based RNA-sequencing Business (2018-2023)
11.2.5 Thermo Fischer Scientific Recent Development
11.3 Oxford Nanopore
11.3.1 Oxford Nanopore Company Detail
11.3.2 Oxford Nanopore Business Overview
11.3.3 Oxford Nanopore NGS-based RNA-sequencing Introduction
11.3.4 Oxford Nanopore Revenue in NGS-based RNA-sequencing Business (2018-2023)
11.3.5 Oxford Nanopore Recent Development
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Detail
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies NGS-based RNA-sequencing Introduction
11.4.4 Agilent Technologies Revenue in NGS-based RNA-sequencing Business (2018-2023)
11.4.5 Agilent Technologies Recent Development
11.5 BGI
11.5.1 BGI Company Detail
11.5.2 BGI Business Overview
11.5.3 BGI NGS-based RNA-sequencing Introduction
11.5.4 BGI Revenue in NGS-based RNA-sequencing Business (2018-2023)
11.5.5 BGI Recent Development
11.6 PerkinElmer
11.6.1 PerkinElmer Company Detail
11.6.2 PerkinElmer Business Overview
11.6.3 PerkinElmer NGS-based RNA-sequencing Introduction
11.6.4 PerkinElmer Revenue in NGS-based RNA-sequencing Business (2018-2023)
11.6.5 PerkinElmer Recent Development
11.7 QIAGEN
11.7.1 QIAGEN Company Detail
11.7.2 QIAGEN Business Overview
11.7.3 QIAGEN NGS-based RNA-sequencing Introduction
11.7.4 QIAGEN Revenue in NGS-based RNA-sequencing Business (2018-2023)
11.7.5 QIAGEN Recent Development
11.8 Eurofins Scientific
11.8.1 Eurofins Scientific Company Detail
11.8.2 Eurofins Scientific Business Overview
11.8.3 Eurofins Scientific NGS-based RNA-sequencing Introduction
11.8.4 Eurofins Scientific Revenue in NGS-based RNA-sequencing Business (2018-2023)
11.8.5 Eurofins Scientific Recent Development
11.9 Roche
11.9.1 Roche Company Detail
11.9.2 Roche Business Overview
11.9.3 Roche NGS-based RNA-sequencing Introduction
11.9.4 Roche Revenue in NGS-based RNA-sequencing Business (2018-2023)
11.9.5 Roche Recent Development
11.10 Takara Bio
11.10.1 Takara Bio Company Detail
11.10.2 Takara Bio Business Overview
11.10.3 Takara Bio NGS-based RNA-sequencing Introduction
11.10.4 Takara Bio Revenue in NGS-based RNA-sequencing Business (2018-2023)
11.10.5 Takara Bio Recent Development
11.11 GENEWIZ
11.11.1 GENEWIZ Company Detail
11.11.2 GENEWIZ Business Overview
11.11.3 GENEWIZ NGS-based RNA-sequencing Introduction
11.11.4 GENEWIZ Revenue in NGS-based RNA-sequencing Business (2018-2023)
11.11.5 GENEWIZ Recent Development
11.12 Hamilton
11.12.1 Hamilton Company Detail
11.12.2 Hamilton Business Overview
11.12.3 Hamilton NGS-based RNA-sequencing Introduction
11.12.4 Hamilton Revenue in NGS-based RNA-sequencing Business (2018-2023)
11.12.5 Hamilton Recent Development
11.13 Macrogen
11.13.1 Macrogen Company Detail
11.13.2 Macrogen Business Overview
11.13.3 Macrogen NGS-based RNA-sequencing Introduction
11.13.4 Macrogen Revenue in NGS-based RNA-sequencing Business (2018-2023)
11.13.5 Macrogen Recent Development
11.14 Zymo Research
11.14.1 Zymo Research Company Detail
11.14.2 Zymo Research Business Overview
11.14.3 Zymo Research NGS-based RNA-sequencing Introduction
11.14.4 Zymo Research Revenue in NGS-based RNA-sequencing Business (2018-2023)
11.14.5 Zymo Research Recent Development
11.15 Tecan Genomics
11.15.1 Tecan Genomics Company Detail
11.15.2 Tecan Genomics Business Overview
11.15.3 Tecan Genomics NGS-based RNA-sequencing Introduction
11.15.4 Tecan Genomics Revenue in NGS-based RNA-sequencing Business (2018-2023)
11.15.5 Tecan Genomics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global NGS-based RNA-sequencing Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of Sequencing by Synthesis
Table 3. Key Players of Ion Semiconductor Sequencing
Table 4. Key Players of Single-molecule Real-time Sequencing
Table 5. Key Players of Nanopore Sequencing
Table 6. Global NGS-based RNA-sequencing Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 7. Global NGS-based RNA-sequencing Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 8. Global NGS-based RNA-sequencing Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global NGS-based RNA-sequencing Market Share by Region (2018-2023)
Table 10. Global NGS-based RNA-sequencing Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 11. Global NGS-based RNA-sequencing Market Share by Region (2024-2034)
Table 12. NGS-based RNA-sequencing Market Trends
Table 13. NGS-based RNA-sequencing Market Drivers
Table 14. NGS-based RNA-sequencing Market Challenges
Table 15. NGS-based RNA-sequencing Market Restraints
Table 16. Global NGS-based RNA-sequencing Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global NGS-based RNA-sequencing Market Share by Players (2018-2023)
Table 18. Global Top NGS-based RNA-sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NGS-based RNA-sequencing as of 2024)
Table 19. Ranking of Global Top NGS-based RNA-sequencing Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by NGS-based RNA-sequencing Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players NGS-based RNA-sequencing Product Solution and Service
Table 23. Date of Enter into NGS-based RNA-sequencing Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global NGS-based RNA-sequencing Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global NGS-based RNA-sequencing Revenue Market Share by Type (2018-2023)
Table 27. Global NGS-based RNA-sequencing Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 28. Global NGS-based RNA-sequencing Revenue Market Share by Type (2024-2034)
Table 29. Global NGS-based RNA-sequencing Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global NGS-based RNA-sequencing Revenue Market Share by Application (2018-2023)
Table 31. Global NGS-based RNA-sequencing Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 32. Global NGS-based RNA-sequencing Revenue Market Share by Application (2024-2034)
Table 33. North America NGS-based RNA-sequencing Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 34. North America NGS-based RNA-sequencing Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America NGS-based RNA-sequencing Market Size by Country (2024-2034) & (US$ Million)
Table 36. Europe NGS-based RNA-sequencing Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 37. Europe NGS-based RNA-sequencing Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe NGS-based RNA-sequencing Market Size by Country (2024-2034) & (US$ Million)
Table 39. Asia-Pacific NGS-based RNA-sequencing Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 40. Asia-Pacific NGS-based RNA-sequencing Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific NGS-based RNA-sequencing Market Size by Region (2024-2034) & (US$ Million)
Table 42. Latin America NGS-based RNA-sequencing Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 43. Latin America NGS-based RNA-sequencing Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America NGS-based RNA-sequencing Market Size by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa NGS-based RNA-sequencing Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 46. Middle East & Africa NGS-based RNA-sequencing Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa NGS-based RNA-sequencing Market Size by Country (2024-2034) & (US$ Million)
Table 48. Illumina Company Detail
Table 49. Illumina Business Overview
Table 50. Illumina NGS-based RNA-sequencing Product
Table 51. Illumina Revenue in NGS-based RNA-sequencing Business (2018-2023) & (US$ Million)
Table 52. Illumina Recent Development
Table 53. Thermo Fischer Scientific Company Detail
Table 54. Thermo Fischer Scientific Business Overview
Table 55. Thermo Fischer Scientific NGS-based RNA-sequencing Product
Table 56. Thermo Fischer Scientific Revenue in NGS-based RNA-sequencing Business (2018-2023) & (US$ Million)
Table 57. Thermo Fischer Scientific Recent Development
Table 58. Oxford Nanopore Company Detail
Table 59. Oxford Nanopore Business Overview
Table 60. Oxford Nanopore NGS-based RNA-sequencing Product
Table 61. Oxford Nanopore Revenue in NGS-based RNA-sequencing Business (2018-2023) & (US$ Million)
Table 62. Oxford Nanopore Recent Development
Table 63. Agilent Technologies Company Detail
Table 64. Agilent Technologies Business Overview
Table 65. Agilent Technologies NGS-based RNA-sequencing Product
Table 66. Agilent Technologies Revenue in NGS-based RNA-sequencing Business (2018-2023) & (US$ Million)
Table 67. Agilent Technologies Recent Development
Table 68. BGI Company Detail
Table 69. BGI Business Overview
Table 70. BGI NGS-based RNA-sequencing Product
Table 71. BGI Revenue in NGS-based RNA-sequencing Business (2018-2023) & (US$ Million)
Table 72. BGI Recent Development
Table 73. PerkinElmer Company Detail
Table 74. PerkinElmer Business Overview
Table 75. PerkinElmer NGS-based RNA-sequencing Product
Table 76. PerkinElmer Revenue in NGS-based RNA-sequencing Business (2018-2023) & (US$ Million)
Table 77. PerkinElmer Recent Development
Table 78. QIAGEN Company Detail
Table 79. QIAGEN Business Overview
Table 80. QIAGEN NGS-based RNA-sequencing Product
Table 81. QIAGEN Revenue in NGS-based RNA-sequencing Business (2018-2023) & (US$ Million)
Table 82. QIAGEN Recent Development
Table 83. Eurofins Scientific Company Detail
Table 84. Eurofins Scientific Business Overview
Table 85. Eurofins Scientific NGS-based RNA-sequencing Product
Table 86. Eurofins Scientific Revenue in NGS-based RNA-sequencing Business (2018-2023) & (US$ Million)
Table 87. Eurofins Scientific Recent Development
Table 88. Roche Company Detail
Table 89. Roche Business Overview
Table 90. Roche NGS-based RNA-sequencing Product
Table 91. Roche Revenue in NGS-based RNA-sequencing Business (2018-2023) & (US$ Million)
Table 92. Roche Recent Development
Table 93. Takara Bio Company Detail
Table 94. Takara Bio Business Overview
Table 95. Takara Bio NGS-based RNA-sequencing Product
Table 96. Takara Bio Revenue in NGS-based RNA-sequencing Business (2018-2023) & (US$ Million)
Table 97. Takara Bio Recent Development
Table 98. GENEWIZ Company Detail
Table 99. GENEWIZ Business Overview
Table 100. GENEWIZ NGS-based RNA-sequencing Product
Table 101. GENEWIZ Revenue in NGS-based RNA-sequencing Business (2018-2023) & (US$ Million)
Table 102. GENEWIZ Recent Development
Table 103. Hamilton Company Detail
Table 104. Hamilton Business Overview
Table 105. Hamilton NGS-based RNA-sequencing Product
Table 106. Hamilton Revenue in NGS-based RNA-sequencing Business (2018-2023) & (US$ Million)
Table 107. Hamilton Recent Development
Table 108. Macrogen Company Detail
Table 109. Macrogen Business Overview
Table 110. Macrogen NGS-based RNA-sequencing Product
Table 111. Macrogen Revenue in NGS-based RNA-sequencing Business (2018-2023) & (US$ Million)
Table 112. Macrogen Recent Development
Table 113. Zymo Research Company Detail
Table 114. Zymo Research Business Overview
Table 115. Zymo Research NGS-based RNA-sequencing Product
Table 116. Zymo Research Revenue in NGS-based RNA-sequencing Business (2018-2023) & (US$ Million)
Table 117. Zymo Research Recent Development
Table 118. Tecan Genomics Company Detail
Table 119. Tecan Genomics Business Overview
Table 120. Tecan Genomics NGS-based RNA-sequencing Product
Table 121. Tecan Genomics Revenue in NGS-based RNA-sequencing Business (2018-2023) & (US$ Million)
Table 122. Tecan Genomics Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global NGS-based RNA-sequencing Market Size Comparison by Type (2023-2034) & (US$ Million)
Figure 2. Global NGS-based RNA-sequencing Market Share by Type: 2024 VS 2034
Figure 3. Sequencing by Synthesis Features
Figure 4. Ion Semiconductor Sequencing Features
Figure 5. Single-molecule Real-time Sequencing Features
Figure 6. Nanopore Sequencing Features
Figure 7. Global NGS-based RNA-sequencing Market Size Comparison by Application (2023-2034) & (US$ Million)
Figure 8. Global NGS-based RNA-sequencing Market Share by Application: 2024 VS 2034
Figure 9. Research & Academia Case Studies
Figure 10. Hospitals & Clinics Case Studies
Figure 11. Pharmaceutical & Biotechnology Companies Case Studies
Figure 12. Others Case Studies
Figure 13. NGS-based RNA-sequencing Report Years Considered
Figure 14. Global NGS-based RNA-sequencing Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 15. Global NGS-based RNA-sequencing Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 16. Global NGS-based RNA-sequencing Market Share by Region: 2024 VS 2034
Figure 17. Global NGS-based RNA-sequencing Market Share by Players in 2024
Figure 18. Global Top NGS-based RNA-sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NGS-based RNA-sequencing as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by NGS-based RNA-sequencing Revenue in 2024
Figure 20. North America NGS-based RNA-sequencing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 21. North America NGS-based RNA-sequencing Market Share by Country (2018-2034)
Figure 22. United States NGS-based RNA-sequencing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. Canada NGS-based RNA-sequencing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. Europe NGS-based RNA-sequencing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. Europe NGS-based RNA-sequencing Market Share by Country (2018-2034)
Figure 26. Germany NGS-based RNA-sequencing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. France NGS-based RNA-sequencing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. U.K. NGS-based RNA-sequencing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Italy NGS-based RNA-sequencing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Russia NGS-based RNA-sequencing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Nordic Countries NGS-based RNA-sequencing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Asia-Pacific NGS-based RNA-sequencing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Asia-Pacific NGS-based RNA-sequencing Market Share by Region (2018-2034)
Figure 34. China NGS-based RNA-sequencing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. Japan NGS-based RNA-sequencing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. South Korea NGS-based RNA-sequencing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. Southeast Asia NGS-based RNA-sequencing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. India NGS-based RNA-sequencing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Australia NGS-based RNA-sequencing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. Latin America NGS-based RNA-sequencing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Latin America NGS-based RNA-sequencing Market Share by Country (2018-2034)
Figure 42. Mexico NGS-based RNA-sequencing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Brazil NGS-based RNA-sequencing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Middle East & Africa NGS-based RNA-sequencing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Middle East & Africa NGS-based RNA-sequencing Market Share by Country (2018-2034)
Figure 46. Turkey NGS-based RNA-sequencing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 47. Saudi Arabia NGS-based RNA-sequencing Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 48. Illumina Revenue Growth Rate in NGS-based RNA-sequencing Business (2018-2023)
Figure 49. Thermo Fischer Scientific Revenue Growth Rate in NGS-based RNA-sequencing Business (2018-2023)
Figure 50. Oxford Nanopore Revenue Growth Rate in NGS-based RNA-sequencing Business (2018-2023)
Figure 51. Agilent Technologies Revenue Growth Rate in NGS-based RNA-sequencing Business (2018-2023)
Figure 52. BGI Revenue Growth Rate in NGS-based RNA-sequencing Business (2018-2023)
Figure 53. PerkinElmer Revenue Growth Rate in NGS-based RNA-sequencing Business (2018-2023)
Figure 54. QIAGEN Revenue Growth Rate in NGS-based RNA-sequencing Business (2018-2023)
Figure 55. Eurofins Scientific Revenue Growth Rate in NGS-based RNA-sequencing Business (2018-2023)
Figure 56. Roche Revenue Growth Rate in NGS-based RNA-sequencing Business (2018-2023)
Figure 57. Takara Bio Revenue Growth Rate in NGS-based RNA-sequencing Business (2018-2023)
Figure 58. GENEWIZ Revenue Growth Rate in NGS-based RNA-sequencing Business (2018-2023)
Figure 59. Hamilton Revenue Growth Rate in NGS-based RNA-sequencing Business (2018-2023)
Figure 60. Macrogen Revenue Growth Rate in NGS-based RNA-sequencing Business (2018-2023)
Figure 61. Zymo Research Revenue Growth Rate in NGS-based RNA-sequencing Business (2018-2023)
Figure 62. Tecan Genomics Revenue Growth Rate in NGS-based RNA-sequencing Business (2018-2023)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed